Author Correction: An epitope-specific chemically defined nanoparticle vaccine for respiratory syncytial virus

Código QR

Author Correction: An epitope-specific chemically defined nanoparticle vaccine for respiratory syncytial virus

Guardado en:

Detalles Bibliográficos
Autores principales:	Armando Zuniga, Oliver Rassek, Melissa Vrohlings, Aniebrys Marrero-Nodarse, Kerstin Moehle, John A. Robinson, Arin Ghasparian
Formato:	article
Lenguaje:	EN
Publicado:	Nature Portfolio 2021
Materias:	Immunologic diseases. Allergy RC581-607 Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282
Acceso en línea:	https://doaj.org/article/7f3d6229caa145df9f6891d454e2fa99
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

An epitope-specific chemically defined nanoparticle vaccine for respiratory syncytial virus
por: Armando Zuniga, et al.
Publicado: (2021)

CYTOKINE PROFILE IN ADULTS WITH RESPIRATORY SYNCYTIAL VIRAL INFECTION
por: I. A. Klimova, et al.
Publicado: (2018)

Severe acute respiratory syndrome coronavirus 2 and respiratory syncytial virus coinfection in children
por: Milad Zandi, et al.
Publicado: (2021)

Immune response to respiratory syncytial virus infection (<i>Orthopneumovirus</i>)
por: A. A. Nikonova, et al.
Publicado: (2021)

Sirtuin 1 regulates mitochondrial function and immune homeostasis in respiratory syncytial virus infected dendritic cells.
por: Srikanth Elesela, et al.
Publicado: (2020)

Autocrine regulation of pulmonary inflammation by effector T-cell derived IL-10 during infection with respiratory syncytial virus.
por: Jie Sun, et al.
Publicado: (2011)

Meteorological drivers of respiratory syncytial virus infections in Singapore
por: Sheikh Taslim Ali, et al.
Publicado: (2020)

ROLE OF PREEXISTING VIRUS-SPECIFIC IgG IN PRIMARY DISEASE AND IN REINFECTION WITH RESPIRATORY SYNCYTIAL VIRUS
por: V. Z. Krivitskaya, et al.
Publicado: (2014)

The Structure of the Human Respiratory Syncytial Virus M2-1 Protein Bound to the Interaction Domain of the Phosphoprotein P Defines the Orientation of the Complex
por: Muniyandi Selvaraj, et al.
Publicado: (2018)

Positive selection results in frequent reversible amino acid replacements in the G protein gene of human respiratory syncytial virus.
por: Viviane F Botosso, et al.
Publicado: (2009)

Cryo-EM structure of the respiratory syncytial virus RNA polymerase
por: Dongdong Cao, et al.
Publicado: (2020)

Epidemic dynamics of respiratory syncytial virus in current and future climates
por: Rachel E. Baker, et al.
Publicado: (2019)

Therapeutic efficacy of a respiratory syncytial virus fusion inhibitor
por: Dirk Roymans, et al.
Publicado: (2017)

The larger attachment glycoprotein of respiratory syncytial virus produced in primary human bronchial epithelial cultures reduces infectivity for cell lines.
por: Tiffany King, et al.
Publicado: (2021)

Utility of the Global Respiratory Severity Score for predicting the need for respiratory support in infants with respiratory syncytial virus infection.
por: Jun Kubota, et al.
Publicado: (2021)

Acute respiratory infections in hospitalized children in Vientiane, Lao PDR – the importance of Respiratory Syncytial Virus
por: Van Hoan Nguyen, et al.
Publicado: (2017)

Surveillance of respiratory syncytial virus infections in adults, Austria, 2017 to 2019
por: Lorenz Schubert, et al.
Publicado: (2021)

Airway response to respiratory syncytial virus has incidental antibacterial effects
por: Charles J. Sande, et al.
Publicado: (2019)

Assessment and optimization of respiratory syncytial virus prophylaxis in Connecticut, 1996–2013
por: Ben Artin, et al.
Publicado: (2021)

Development of surface engineered antigenic exosomes as vaccines for respiratory syncytial virus
por: Suyeon Hong, et al.
Publicado: (2021)

Rhinovirus-associated wheezing in infancy Comparison with respiratory syncytial virus bronchiolitis
por: Zamorano R.,Juanita
Publicado: (2005)

Role of CCR3 in respiratory syncytial virus infection of airway epithelial cells
por: Vincent Wellemans, et al.
Publicado: (2021)

Respiratory syncytial virus: promising progress against a leading cause of pneumonia
por: Amy Sarah Ginsburg, et al.
Publicado: (2021)

Functional organization of cytoplasmic inclusion bodies in cells infected by respiratory syncytial virus
por: Vincent Rincheval, et al.
Publicado: (2017)

Genetic diversity and molecular evolution of human respiratory syncytial virus A and B
por: Jie-Mei Yu, et al.
Publicado: (2021)

A morphological transformation in respiratory syncytial virus leads to enhanced complement deposition
por: Jessica P Kuppan, et al.
Publicado: (2021)

Engineered mRNA-expressed antibodies prevent respiratory syncytial virus infection
por: Pooja Munnilal Tiwari, et al.
Publicado: (2018)

Review of palivizumab in the prophylaxis of respiratory syncytial virus (RSV) in high-risk infants
por: Asunci&oacute;n Mej&iacute;as, et al.
Publicado: (2008)

Severe respiratory disease caused by human respiratory syncytial virus impairs language learning during early infancy
por: Marcela Peña, et al.
Publicado: (2020)

Factors Associated with Severe Lower Respiratory Tract Infection from Respiratory Syncytial Virus (RSV) in Thai Children
por: Atipotsawee Tungsupreechameth, et al.
Publicado: (2021)

Integrated omics endotyping of infants with respiratory syncytial virus bronchiolitis and risk of childhood asthma
por: Yoshihiko Raita, et al.
Publicado: (2021)

Viral N 6-methyladenosine upregulates replication and pathogenesis of human respiratory syncytial virus
por: Miaoge Xue, et al.
Publicado: (2019)

Respiratory syncytial virus B sequence analysis reveals a novel early genotype
por: Juan C. Muñoz-Escalante, et al.
Publicado: (2021)

Respiratory syncytial virus promotes Moraxella catarrhalis-induced ascending experimental otitis media.
por: M Elizabeth Brockson, et al.
Publicado: (2012)

Macrophages are required for dendritic cell uptake of respiratory syncytial virus from an infected epithelium.
por: Kelechi Ugonna, et al.
Publicado: (2014)

Author Correction: Airway response to respiratory syncytial virus has incidental antibacterial effects
por: Charles J. Sande, et al.
Publicado: (2019)

Efficacy of a respiratory syncytial virus vaccine candidate in a maternal immunization model
por: Jorge C. G. Blanco, et al.
Publicado: (2018)

Nanodiscs as a therapeutic delivery agent: inhibition of respiratory syncytial virus infection in the lung
por: Numata M, et al.
Publicado: (2013)

Roflumilast inhibits respiratory syncytial virus infection in human differentiated bronchial epithelial cells.
por: Manuel Mata, et al.
Publicado: (2013)

Ozone inactivation of airborne influenza and lack of resistance of respiratory syncytial virus to aerosolization and sampling processes.
por: Marie-Eve Dubuis, et al.
Publicado: (2021)